These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37935319)

  • 41. Human placental mesenchymal stromal cell-derived exosome-enriched extracellular vesicles for chronic cutaneous graft-versus-host disease: A case report.
    Norooznezhad AH; Yarani R; Payandeh M; Hoseinkhani Z; Kiani S; Taghizadeh E; Thakor AS; Mansouri K
    J Cell Mol Med; 2022 Jan; 26(2):588-592. PubMed ID: 34873830
    [No Abstract]   [Full Text] [Related]  

  • 42. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mesenchymal stem cell therapy in hematopoietic stem cell transplantation].
    Goto T; Murata M
    Rinsho Ketsueki; 2018; 59(2):195-204. PubMed ID: 29515075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.
    Ringden O; Baygan A; Remberger M; Gustafsson B; Winiarski J; Khoein B; Moll G; Klingspor L; Westgren M; Sadeghi B
    Stem Cells Transl Med; 2018 Apr; 7(4):325-331. PubMed ID: 29533533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mesenchymal stem cells for treatment of graft-versus-host disease].
    Najima Y
    Rinsho Ketsueki; 2017; 58(12):2440-2449. PubMed ID: 29332881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Li T; Luo C; Zhang J; Wei L; Sun W; Xie Q; Liu Y; Zhao Y; Xu S; Wang L
    Stem Cell Res Ther; 2021 Apr; 12(1):246. PubMed ID: 33879242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
    Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Umbilical cord blood-derived mesenchymal stem cells ameliorate graft-versus-host disease following allogeneic hematopoietic stem cell transplantation through multiple immunoregulations.
    Wu QL; Liu XY; Nie DM; Zhu XX; Fang J; You Y; Zhong ZD; Xia LH; Hong M
    J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):477-484. PubMed ID: 26223913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesenchymal Stromal Cells in Hematopoietic Stem Cell Transplantation.
    Bernardo ME; Locatelli F
    Methods Mol Biol; 2016; 1416():3-20. PubMed ID: 27236663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial.
    Huang R; Chen T; Wang S; Wang J; Su Y; Liu J; Zhang Y; Ma X; Wen Q; Kong P; Zhang C; Gao L; Zhong JF; Gao L; Zhang X
    JAMA Oncol; 2024 Feb; 10(2):220-226. PubMed ID: 38153755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment with a rho kinase inhibitor improves survival from graft-versus-host disease in mice after MHC-haploidentical hematopoietic cell transplantation.
    Iyengar S; Zhan C; Lu J; Korngold R; Schwartz DH
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1104-11. PubMed ID: 24796280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence.
    Murata M; Terakura S; Wake A; Miyao K; Ikegame K; Uchida N; Kataoka K; Miyamoto T; Onizuka M; Eto T; Doki N; Ota S; Sato M; Hashii Y; Ichinohe T; Fukuda T; Atsuta Y; Okamoto S; Teshima T
    Bone Marrow Transplant; 2021 Oct; 56(10):2355-2366. PubMed ID: 33976381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study.
    Jurado M; De La Mata C; Ruiz-García A; López-Fernández E; Espinosa O; Remigia MJ; Moratalla L; Goterris R; García-Martín P; Ruiz-Cabello F; Garzón S; Pascual MJ; Espigado I; Solano C
    Cytotherapy; 2017 Aug; 19(8):927-936. PubMed ID: 28662983
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IFN-γ gene loaded human umbilical mesenchymal stromal cells targeting therapy for Graft-versus-host disease.
    Li H; Liu Q; Gao X; Zhang D; Mao S; Jia Y
    Int J Pharm; 2021 Jan; 592():120058. PubMed ID: 33220383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human mesenchymal stem cells suppress donor CD4(+) T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease.
    Tobin LM; Healy ME; English K; Mahon BP
    Clin Exp Immunol; 2013 May; 172(2):333-48. PubMed ID: 23574329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mesenchymal stem cells targeting the GVHD.
    Wang L; Zhao RC
    Sci China C Life Sci; 2009 Jul; 52(7):603-9. PubMed ID: 19641864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality Control Analysis of Mesenchymal Stem/Stromal Cells During Investigational New Drug Application for GvHD Administration in China.
    Wang A; Zhang L; Zhao M; Yu H
    Curr Stem Cell Res Ther; 2023; 18(8):1032-1040. PubMed ID: 35619293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mesenchymal stromal/stem cell therapy for acute graft versus host disease: the next step].
    Miura Y; Fujii S
    Rinsho Ketsueki; 2020; 61(8):953-958. PubMed ID: 32908060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mesenchymal stem cells (MSC) delays the occurrence of graft-versus-host disease(GVHD) in the inhibition of hematopoietic stem cells in major histocompatibility complex semi-consistent mice by regulating the expression of IFN-γ/IL-6.
    Wang Y
    Bioengineered; 2021 Dec; 12(1):4500-4507. PubMed ID: 34308757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.